Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006949-13Phase 2Terminated
Phase 2 trial of rotigotine in hemispatial neglect and stroke, sponsored by University College London. Primary endpoint: Completion of study protocol. Started Aug 2007; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006949-13.